Trial · NCT02720081
Results by group94
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 94
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Baseline Pre-dose Forced Expiratory Volume in One Second (FEV1) | MK-1029 150 mg + Montelukast 10 mg | 2.264 | Standard Deviation 0.566 | Liter | |
| Baseline Pre-dose Forced Expiratory Volume in One Second (FEV1) | MK-1029 Placebo + Montelukast 10 mg | 2.234 | Standard Deviation 0.612 | Liter | |
| Percentage of Days With Worsening Asthma Average Over Weeks 3 to 6 | MK-1029 150 mg + Montelukast 10 mg | 16.970 | 95% Confidence Interval 10.115 to 23.826 | Percentage of days | |
| Percentage of Days With Worsening Asthma Average Over Weeks 3 to 6 | MK-1029 Placebo + Montelukast 10 mg | 21.746 | 95% Confidence Interval 14.291 to 29.201 | Percentage of days | |
| Percentage of Participants Who Experienced an Adverse Event (AE) | MK-1029 150 mg + Montelukast 10 mg | 25.7 | Percentage of participants | ||
| Percentage of Participants Who Experienced an Adverse Event (AE) | MK-1029 Placebo + Montelukast 10 mg | 26.1 | Percentage of participants | ||
| Percentage of Participants Who Discontinued Study Drug Due to an AE | MK-1029 150 mg + Montelukast 10 mg | 0.0 | Percentage of participants | ||
| Percentage of Participants Who Discontinued Study Drug Due to an AE | MK-1029 Placebo + Montelukast 10 mg | 4.3 | Percentage of participants | ||
| Change From Baseline in Alkaline Phosphatase (ALP) at Week 6 | MK-1029 150 mg + Montelukast 10 mg | Baseline | 61.16 | Standard Deviation 19.05 | IU/L |
| Change From Baseline in Alkaline Phosphatase (ALP) at Week 6 | MK-1029 Placebo + Montelukast 10 mg | Baseline | 67.96 | Standard Deviation 21.17 | IU/L |
| Change From Baseline in Alkaline Phosphatase (ALP) at Week 6 | MK-1029 150 mg + Montelukast 10 mg | Change at Week 6 | -0.83 | Standard Deviation 7.68 | IU/L |
| Change From Baseline in Alkaline Phosphatase (ALP) at Week 6 | MK-1029 Placebo + Montelukast 10 mg | Change at Week 6 | 0.44 | Standard Deviation 9.98 | IU/L |
| Change From Baseline in Alanine Aminotransferase (ALT) at Week 6 | MK-1029 150 mg + Montelukast 10 mg | Baseline | 22.33 | Standard Deviation 12.75 | IU/L |
| Change From Baseline in Alanine Aminotransferase (ALT) at Week 6 | MK-1029 Placebo + Montelukast 10 mg | Baseline | 19.35 | Standard Deviation 9.77 | IU/L |
| Change From Baseline in Alanine Aminotransferase (ALT) at Week 6 | MK-1029 150 mg + Montelukast 10 mg | Change at Week 6 | -0.99 | Standard Deviation 9.84 | IU/L |
| Change From Baseline in Alanine Aminotransferase (ALT) at Week 6 | MK-1029 Placebo + Montelukast 10 mg | Change at Week 6 | 0.34 | Standard Deviation 6.31 | IU/L |
| Change From Baseline in Aspartate Aminotransferase (AST) at Week 6 | MK-1029 150 mg + Montelukast 10 mg | Baseline | 23.53 | Standard Deviation 10.28 | IU/L |
| Change From Baseline in Aspartate Aminotransferase (AST) at Week 6 | MK-1029 Placebo + Montelukast 10 mg | Baseline | 20.64 | Standard Deviation 7.62 | IU/L |
| Change From Baseline in Aspartate Aminotransferase (AST) at Week 6 | MK-1029 150 mg + Montelukast 10 mg | Change at Week 6 | -0.09 | Standard Deviation 12.52 | IU/L |
| Change From Baseline in Aspartate Aminotransferase (AST) at Week 6 | MK-1029 Placebo + Montelukast 10 mg | Change at Week 6 | 0.76 | Standard Deviation 7.67 | IU/L |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02720081/results